Osimertinib, also known as Tagrisso, is a revolutionary targeted therapy medication used to treat non-small cell lung cancer (NSCLC) with mutations in the EGFR gene. This article aims to provide a comprehensive overview of osimertinib, its uses, benefits, and potential side effects. By addressing the following key requirements, we will delve into the intricacies of this groundbreaking...